rimabotulinumtoxinB

DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

Adverse drug reactions:  

Frequency Not Defined  

Accommodation disturbances  

Injection site pain  

Flu-like symptoms  

Angioedema  

Urticaria  

Rash  

Constipation  

Dry eye  

Headache  

Dry mouth  

Dysphagia  

Dyspepsia  

Pregnancy warnings:    

• US FDA pregnancy category: Not assigned 

Breastfeeding warnings: 

• The release of the drug into the human breastmilk is unknown  
• The release of the drug into the animal milk is unknown 
• Therefore, the use of the drug is not recommended 

Pregnancy Categories:      

• Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first trimester or the later trimester      
• Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women      
• Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women      
• Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits      
• Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women      
• Category N: There is no data available for the drug under this category     

 

Patient Information Leaflet  

Generic Name: rimabotulinumtoxinB 

Pronounciation: RYE-ma-BOT-ue-LYE-num-TOX-in-B 

Why do we use rimabotulinumtoxinB? 

rimabotulinumtoxinB belongs to the class of anticholinergic agents and Skeletal muscle relaxants used to treat cervical dystonia and drooling (sialorrhea).